Top Markets
#1 Islamic Coin Islamic Coin +151.60%
#2 Black Phoenix Black Phoenix +35.36%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#4 Akedo Akedo +16.20%
#5 Fake World Assets Fake World Assets +15.77%
#6 Palladium Network Palladium Network +15.41%
#7 HOME HOME +12.57%
#8 clBTC clBTC +11.81%
#9 DoubleZero DoubleZero +11.79%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.76%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Bio-Path Holdings, Inc. Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.

BPTH
Kedudukan dalam Saham #39844
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on... Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refractory/relapsed lymphoma and chronic lymphocytic leukemia. Another promising asset, Liposomal STAT3, is in preclinical development, targeting pancreatic cancer, non-small cell lung cancer, and AML. Furthermore, prexigebersen-A is under development for various solid tumors. Bio-Path Holdings, Inc., founded in 2007, is headquartered in Bellaire, Texas.
Harga Saham
$0.035
Disegerakkan terakhir: 2026-08-13
Modal Pasaran
$326.98K
Perubahan (1 hari)
-12.50%
Perubahan (1 tahun)
-74.55%
Negara
US
Perdagangan Bio-Path Holdings, Inc. (BPTH)

Kategori

Healthcare
Sejarah harga saham bagi Bio-Path Holdings, Inc. (BPTH)
Harga penutupan tertinggi: $0.04 pada 2026-08-01

Harga penutupan terendah: $2.50K pada 2006-02-01
Sejarah harga saham Bio-Path Holdings, Inc. dari 2006 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -9.36%
2025 -91.80%
2024 -91.13%
2023 -66.41%
2022 -65.24%
2021 16.03%
2020 -52.69%
2019 59.95%
2018 -88.85%
2017 -82.76%
2016 -18.86%
2015 -40.35%
2014 -11.72%
2013 803.53%
2012 3.58%
2011 -14.96%
2010 -14.88%
2009 4.80%
2008 -52.90%
2007 18.00%
2006 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE